肾康注射液治疗慢性肾衰临床疗效观察

目的:观察新型中药复方制剂肾康注射液治疗慢性肾功能衰竭(CRF)的临床疗效。方法:将84例CRF患者随机分为2组。在常规降压治疗基础上,治疗组(54例)给予肾康注射液60～100mL,溶于10%葡萄糖注射液300mL或生理盐水300mL中静脉滴注,1次.d-1,30d为一个疗程;对照组(30例)给予复方丹参注射液250mL静脉滴注,1次.d-1,30d为一个疗程。结果:与对照组比较,治疗组的血清肌酐、尿素氮下降更显著(P<0.05);内生肌酐清除率上升亦更显著(P<0.05)。结论:肾康注射液对CRF的临床治疗具有重要意义,且疗效优于复方丹参注射液。

Observation of Curative Efficacy of Shenkang Injection for Chronic Renal Failure

OBJECTIVE:To observe the clinical efficacy of Shenkang injection,a new compound preparation for chronic renal failure(CRF).METHODS:A total of 84 CRF patients were randomly divided into two groups:the treatment group(n=54)was given routine antihypertensive therapy and infused(iv gtt)with Shenkang injection 60～ 100mL(dissolved in 10% GS 300mL or NS 300mL)q.d for 30d;the control group(n=30)was infused(iv gtt)with Compound danshen injection 250mL q.d for 30d.RESULTS:As compared with the control group,serum levels of creatinine and urea nitrogen(UN)in treatment group had a greater reduction(P<0.05),and the endogenous creatinine clearance rate had a greater increase than in control group(P<0.05).CONCLUSION:Shenkang injection is of great clinical importance for CRF,and its efficacy is superior to that of Compound danshen injection.